MoonLake Immunotherapeutics (MLTX) EPS (Weighted Average and Diluted) Growth (3y) (2024 - 2026)
MoonLake Immunotherapeutics (MLTX) EPS (Weighted Average and Diluted) Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 59.54% |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 22,777.33% |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 1,857.10% |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 41.33% |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 14.33% |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | MoonLake Immunotherapeutics | 1.25 Bn | 888.66 Mn | - | -62.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -62.12% |
| Dec 31, 2025 | -28.86% |
| Sep 30, 2025 | -59.71% |
| Jun 30, 2025 | -36.78% |
| Mar 31, 2025 | 41.64% |
| Dec 31, 2024 | 52.78% |
| Sep 30, 2024 | 40.29% |
| Jun 30, 2024 | 48.77% |
| Mar 31, 2024 | -180.20% |